Proteros and Adrestia initiate multi-target partnership to discover first-in-class drugs for intractable genetic diseases
October 25, 2022 08:00 ET
|
Proteros biostructures GmbH
Proteros selected by Adrestia for its cutting-edge structure-based drug discovery engineProteros to support Adrestia in the discovery of first-in-class drugs for intractable genetic diseasesSignals...